TY  - JOUR
AU  - Mostaza, José M
AU  - Suárez-Fernández, Carmen
AU  - Cosín-Sales, Juan
AU  - Gómez-Huelgas, Ricardo
AU  - Brotons, Carlos
AU  - Araujo, Francisco Pestana
AU  - Borrayo, Gabriela
AU  - Ruiz, Emilio
AU  - VULCANO investigators
PY  - 2022
DO  - 10.1186/s12872-022-03013-w
UR  - http://hdl.handle.net/10668/20264
T2  - BMC cardiovascular disorders
AB  - Cardiovascular (CV) polypills are a useful baseline treatment to prevent CV diseases by combining different drug classes in a single pill to simultaneously target more than one risk factor. The aim of the present trial was to determine whether the...
LA  - en
KW  - Cardiovascular disease
KW  - Cardiovascular risk factors
KW  - Fixed-dose combination
KW  - Non-inferiority trial
KW  - Polypill
KW  - Primary prevention
KW  - Humans
KW  - Antihypertensive Agents
KW  - Cholesterol, LDL
KW  - Drug Combinations
KW  - Cardiovascular Diseases
KW  - Cholesterol
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
TI  - Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial.
TY  - research article
VL  - 22
ER  -